No Detail Found!

Reducing the Burden of Diabetes Mellitus: Is It Achievable?

Author(s)
Rafay iqbal Department of Family Medicine, Aga Khan University,Karachi,Pakistan
Raheel Ahmad Department of Family Medicine, Aga Khan University,Karachi,Pakistan
Aisha Ambreen Department of Oncology, Aga Khan University,Karachi,Pakistan
Abstract
Diabetes mellitus is rapidly on the rise globally, particularly in low- and middle-income countries. Pakistan has emerged with the highest prevalence of diabetes by percentage according to recent estimates. Evidence is available for diferent strategies to reduce this burden. Screening high-risk individuals can reduce burden of undiagnosed diabetes and improve outcomes. Although prediabetes can progress to type 2 diabetes, it has the potential to regress to normoglycaemia as well. Interventions like lifestyle modifications and metformin in high-risk individuals can reduce the risk of progression to diabetes. Furthermore, there is a potential to reverse diabetes in some individuals in the early years after diagnosis with a low-calorie diet, carbohydrate restriction or bariatric surgery.
Publication Details
Page(s) 269-274
Published Journal: Liaquat National Journal of Primary Care, Volume: 6, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Diabetes mellitus, Prevalence, prevention, Diabetes mellitus, Prevalence, Prediabetes, Remission
References
Lin X,Xu Y,Pan X,Xu J,Ding Y,Sun X .2020 .Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep, 10(1) : 14790.
Diabetes .2022 .. 2021 [cited 10 Jan, : .
.2022 .Diabetes is “a pandemic of unprecedented magnitude” now afecting one in 10 adults worldwide. 2021 [cited 10 Jan, 8227(21) : 00493-9.
.2024 .-2024. World Obesity Federation. 2024 [cited 7th April, : .
Sun H,Saeedi P,Karuranga S,Pinkepank M,Ogurtsova K,Duncan BB .2021 .IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract, : 109119.
.2022 .. UNFPA. [cited 3 Jan, : .
Aamir AH,Ul-Haq Z,Mahar SA,Qureshi FM,Ahmad I,Jawa A .2019 .9(2): e025300. -025300, : .
Basit A,Fawwad A,Qureshi H,Shera AS,Members N. .2018 .8(8): e020961. -020961, : 2017.
.2022 .. Global Report on Diabetes [Internet]. WHO. 2016 [cited 3 January, : .
Grifin SJ,Rutten G,Khunti K,Witte DR,Lauritzen T,Sharp SJ .2019 .Long-term efects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial. Lancet Diabetes Endocrinol, 8587(19) : 30349-3.
Abdul Basit K,Fawwad A,Riaz M,Tahir B,Khalid M,Basit A .2021 .Risk Assessment of Pakistani Individual for Diabetes (RAPID) - Findings from Second National Diabetes Survey of Pakistan (NDSP). Diabetes Metab Syndr Obes, 14 : 257-63.
.2022 .. Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care, 45(Suppl) : S17-S38.
Chung S,Azar KM,Baek M,Lauderdale DS,Palaniappan LP .2014 .Reconsidering the age thresholds for type II diabetes screening in the U. Am J Prev Med, 05(4) : 375-81.
Jafar TH,Qadri Z,Islam M,Hatcher J,Bhutta ZA,Chaturvedi N. .2007 .Rise in childhood obesity with persistently high rates of undernutrition among urban school-aged Indo-Asian children. Arch Dis Child, 93(5) : 373-8.
Casqueiro J,Casqueiro J,Alves C. .2012 .Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab, 16(Suppl1) : 94253-8210.
Tabak AG,Herder C,Rathmann W,Brunner EJ,Kivimaki M. .2012 .Prediabetes: a high-risk state for diabetes development. Lancet, 6736(12) : 60283-9.
Ligthart S,van Herpt TT,Leening MJ,Kavousi M,Hofman A,Stricker BH .2016 .Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol, 8587(15) : 00362-9.
Ramachandran A,Snehalatha C,Mary S,Mukesh B,Bhaskar AD,Vijay V .2006 .The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia, 49(2) : 289-97.
.2022 .American Diabetes Association Professional Practice Committee. 3. Prevention or delay of type 2 diabetes and associated comorbidities: standards of medical care in diabetes-2022. Diabetes Care, 45(Supplement) : S39-S45.
Liu X,Wu S,Song Q,Wang X .2021 .3): e019045. J Am Heart Assoc, 10 : .
Knowler WC,Barrett-Connor E,Fowler SE,Hamman RF,Lachin JM,Walker EA .2002 .Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 346(6) : 393-403.
Diabetes .2015 .Prevention Program Research G. Long-term efects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol, 8587(15) : 00291-0.
Lindstrom J,Ilanne-Parikka P,Peltonen M,Aunola S,Eriksson JG,Hemio K .2006 .Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet, 6736(06) : 69701-8.
Gong Q,Zhang P,Wang J,Ma J,An Y,Chen Y .2019 .Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol, 8587(19) : 30093-2.
Hydrie MZ,Basit A,Shera AS,Hussain A .2015 .Corrigendum to Efect of intervention in subjects with high risk of diabetes mellitus in Pakistan. J Nutr Metab, : 289294.
Diabetes .2019 .Prevention Program Research G. Long-term efects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care, 42(4) : 1970-8.
Chen Z,Hu H,Chen M,Luo X,Yao W,Liang Q .2020 .Association of triglyceride to high-density lipoprotein cholesterol ratio and incident of diabetes mellitus: a secondary retrospective analysis based on a Chinese cohort study. Lipids Health Dis, 19(1) : 33.
.2022 .Type 2 diabetes: prevention in people at high risk [Internet]. NICE. 2012 [cited 17 Feb, : .
Domecq JP,Prutsky G,Elraiyah T,Wang Z,Mauck KF,Brito JP .2019 .Medications afecting the biochemical conversion to type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab, : 01269.
Yanovski SZ,Yanovski JA .2013 .Long-term drug treatment for obesity: a systematic and clinical review. JAMA, 311(1) : 74-86.
Torgerson JS,Hauptman J,Boldrin MN,Sjostrom L. .2004 .XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1) : 155-61.
Garvey WT,Ryan DH,Henry R,Bohannon NJ,Toplak H,Schwiers M .2014 .Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release. Diabetes Care, 37(4) : 1518-21.
Wilding JPH,Batterham RL,Calanna S,Davies M,Van Gaal LF,Lingvay I .2021 .Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med, 384(11) : 989.
Carlsson LM,Peltonen M,Ahlin S,Anveden A,Bouchard C,Carlsson B .2012 .Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med, 367(8) : 695-704.
.2024 .. Global Diabetes data report 2000 - 2045 [Internet]. IDF. 2021 [cited 6th April, : .
Butt MD,Ong SC,Wahab MU,Rasool MF,Saleem F,Hashmi A .2022 .Cost of illness analysis of type 2 diabetes mellitus: the findings from a lower-middle income country. Int J Environ Res Public Health, 19(19) : .
.2024 .Cost-efective solutions for the prevention of type 2 diabetes [Internet]. IDF. 2016 [cited 7th April, : .
Singh K,Chandrasekaran AM,Bhaumik S,Chattopadhyay K,Gamage AU,Silva P .2018 .8(4): e017809. -017809, : .
Taylor R,Ramachandran A,Yancy WS,Jr. WS,Forouhi NG .2021 .Nutritional basis of type 2 diabetes remission. BMJ, 374 : .
Nagi D,Hambling C,Taylor R C .2019 .Remission of type 2 diabetes: a position statement from the Association of British Clinical Diabetologists (ABCD) and the Primary Care Diabetes Society (PCDS). Br J Diabetes, 19(1) : 73-6.
Mingrone G,Panunzi S,De Gaetano A,Guidone C,Iaconelli A,Nanni G .2015 .Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet, 6736(15) : 00075-6.
Sheng B,Truong K,Spitler H,Zhang L,Tong X,Chen L .2017 .The longterm efects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obes Surg, 27(10) : 2724-32.
Hallberg SJ,Gershuni VM,Hazbun TL,Athinarayanan SJ .2019 .Reversing type 2 diabetes: a narrative review of the evidence. Nutrients, 11(4) : 766.
Steven S,Hollingsworth KG,Al-Mrabeh A,Avery L,Aribisala B,Caslake M .2016 .Very low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care, 39(5) : 1942-15.
Lean MEJ,Leslie WS,Barnes AC,Brosnahan N,Thom G,McCombie L .2019 .Durability of a primary care-led weightmanagement intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol, 8587(19) : 30068-3.
.2021 .No authors listed. 57(th) EASD Annual Meeting of the European Association for the Study of Diabetes. Diabetologia, 64(Suppl 1) : 1-380.
0

Citations

0

Downloads

111

Views